Several cities are opening warming centers to provide shelter to people who need to escape the frigid weather.
Related Posts
This ‘safe haven’ beverage stock is a buy with underappreciated growth potential, says Morgan Stanley
The Wall Street firm upgraded shares to overweight from equal weight.
CVS shares pop 10% on big earnings beat, even as high medical costs drag down insurance unit
It caps off the first full quarter with David Joyner, a longtime CVS executive, as CEO of the troubled retail drugstore chain.
Bristol Myers Squibb plans $2 billion in cost cuts by 2027, issues weak guidance
The company also issued a 2025 guidance that fell short of expectations, as some of the company’s older drugs face competition from cheaper generics.